Biotech Psoriasis Drugs Hit a Cost Ceiling
January 25, 2007
Are biotechnology companies reaching the limits of how much they can charge for their drugs? One sign of that is the sluggish sales of drugs for psoriasis. (New York Times)
January 25, 2007
Are biotechnology companies reaching the limits of how much they can charge for their drugs? One sign of that is the sluggish sales of drugs for psoriasis. (New York Times)